NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 7.2025

作者：Gregory J. Riely, Douglas E. Wood, Dara L. Aisner, Billy W. Loo, Andrea L. Axtell, Jessica R. Bauman, Ankit Bharat, Joe Y. Chang, Aakash Desai, Thomas J. Dilling, Jonathan E. Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aditya Juloori, Rudy P. Lackner, Michael Lanuti, Benjamin Levy, Jules Lin, Christine M. Lovly, Fabien Maldonado, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Dawn Owen, Dwight H. Owen, Sandip Pravin Patel, Tejas Patil, Patricio M. Polanco, Jonathan W. Riess, Ana Lucia Ruano Mendez, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Edwin Yau, Kristina M. Gregory, Lisa Hang · 发表于：Journal of the National Comprehensive Cancer Network · 年份：2025 · DOI：10.6004/jnccn.2025.0043 · 被引用次数：63 · 研究领域：Lung Cancer Treatments and Mutations、Lung Cancer Diagnosis and Treatment、Lung Cancer Research Studies

The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of NSCLC. These NCCN Guidelines Insights discuss recent updates to the NCCN Guidelines, with a focus on systemic therapy options for the treatment of patients with nonmetastatic NSCLC and the corresponding molecular testing considerations.